Page 88 - HIV/AIDS Guidelines
P. 88
naivepatients:effectofsexandethnicity.HIV Med.Mar2006;7(2):85-98.
113.DARTVirologyGroupandTrialTeam.Virologicalresponsetoatriplenucleoside/nucleotideanalogueregimenover48
weeksinHIV-1-infectedadultsinAfrica.AIDS.Jun262006;20(10):1391-1399.
114.MoyleG,HiggsC,TeagueA,etal.Anopen-label,randomizedcomparativepilotstudyofasingle-classquadruple
therapyregimenversusa2-classtripletherapyregimenforindividualsinitiatingantiretroviraltherapy.Antivir Ther.
2006;11(1):73-78.
115.PulsRL,SrasuebkulP,PetoumenosK,etal.Efavirenzversusboostedatazanavirorzidovudineandabacavirin
antiretroviraltreatment-naive,HIV-infectedsubjects:week48datafromtheAltairstudy.Clin Infect Dis.Oct1
2010;51(7):855-864.
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents F-27
Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
